HIV and bone damage
The bones are tilted to urge the weaker as you get more seasoned. This will be overwhelmingly honest on the off chance that you simply got Human Immunodeficiency (HIV) infection. The infection that causes Helps itself can make your bones more likely to break. And several HIV medications can increase your chances of bone loss. Over time, this can cause your bones to turn soft.
If you also lose a lot of bone mass or thickness, your specialist may identify you with osteoporosis. A milder degree of bone incident is called osteopenia. Almost half of all people with HIV develop osteoporosis or osteopenia. They are twice as likely to break a bone than those who do not suffer from the disease. Many things can play a role in increasing the risk of bone thickness and fractures.
Related Conference of HIV and bone damage
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
HIV and bone damage Conference Speakers
Recommended Sessions
- HIV Drug Discovery and Research
- AIDS stigma and discrimination
- Awareness and knowledge on HIV/AIDS, STDs and STIs
- Emerging Technologies towards HIV/AIDS
- HIV & Vaccines
- HIV and Aging
- HIV and AIDS Nursing Care Management
- HIV and bone damage
- HIV and cardiovascular disease
- HIV and Retroviral Diseases
- HIV Diagnosis and Therapy
- HIV in women
- HIV Testing
- HIV/AIDS Nursing and AIDS awareness
- Lived experience of HIV
- Pediatric HIV AIDS
- Side effects of HIV
- Venereal Diseases Prevention and Treatment
- Viral Immunology and Vaccines development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)
